<DOC>
	<DOCNO>NCT01834638</DOCNO>
	<brief_summary>This study ABT-126 treatment cognitive impairment associate schizophrenia ( CIAS ) , long-term extension study study M10-855 ( NCT01655680 ) .</brief_summary>
	<brief_title>Long-term Safety Efficacy ABT-126 Subjects With Schizophrenia : An Extension Study Subjects Completing Study M10-855 ( NCT01655680 )</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>The subject randomize Study M10855 complete Week 26 study . The subject receive one antipsychotic medication . Additional history collect participation Study M10855 provide evidence , investigator 's judgement , subject schizophrenia . The subject experience adverse event abnormal find physical examination , vital sign , laboratory profile , and/or electrocardiogram ( ECG ) measurement Study M10855 indicate subject likely become medically unstable current study . The subject currently take expect prescribed exclude medication without approval AbbVie medical monitor . The subject currently enrol , plan participate , another interventional study course trial .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>schizophrenia</keyword>
</DOC>